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Increased Amount of Type III pN-collagen in AAA
when Compared with AOD
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Objective: the extent of the processing of type III procollagen to type III collagen was determined in nine human
abdominal aortic aneurysms (AAA), and compared with ten samples of aortoiliac occlusive disease (AOD).
Methods: the aminoterminal propeptide (PIIINP) and telopeptide (IIINTP) of type III procollagen and collagen,
respectively, were immunologically measured in the soluble and insoluble fractions of the extracellular matrix. The assay
for PIIINP in the insoluble matrix was further validated.
Results: the insoluble matrices of AAAs contained at least 12 times more incompletely processed type III pN-collagen
than AOD specimens (0.74% and 0.061%, respectively). Also, the soluble extracts of AAAs tended to contain more non-
processed type III pN-collagen than free, properly cleaved aminoterminal propeptide.
Conclusions: the larger amount of type III pN-collagen suggests an alteration in the metabolism of type III collagen in
AAAs. This may partially explain the decreased tensile strength of the aortic tissue.
Key Words: Aneurysm; Atherosclerosis; Collagen; Extracellular matrix.
Introduction pN-collagen, with a retained aminoterminal pro-
peptide.13
Abdominal aortic aneurysms (AAAs) were tra- The aim of this study was to assess the processing
of type III collagen and the proportion of type IIIditionally thought to be caused simply by athero-
sclerosis, but epidemiologic, genetic and biochemical pN-collagen in AAAs using atherosclerotic, but non-
aneurysmal, aorta tissue as control. The presence ofinformation has shown that other etiological factors
are involved as well.1 Several studies have indicated type III pN-collagen prevents the further lateral growth
of type III collagen fibres13 and may also affect collagena familial component,2–4 and type III collagen gene
mutations have, indeed, been shown to contribute to cross-linking at the aminoterminus. Here, we wanted
to characterise the degree of processing of type IIIthe development of AAAs.5 The expansion of infra-
renal AAAs is accompanied by an increase in the collagen in AAAs.
content of total proteins and collagens in the diseased
vessel wall,6 together with a dilutional decrease in the
elastin content7 and the number of the smooth muscle
Materials and Methodscells.8 There is also evidence of increased collagenolytic
and elastolytic activity.9–11
Subjects and tissue samplesCollagens (including at least types I, III, IV, V, VI
and VIII) are, together with elastin, the most abundant
Fresh longitudinal strips were cut from the anteriorextracellular components of the aortic vessel wall. Type
wall of the full-thickness aneurysm sacs of 9 con-III collagen in particular has been suggested to provide
secutive patients (6 men and 3 women, mean age 72the aortic tissue with tensile strength.12 Type III col-
years, range 67 to 84 years). Seven were from patientslagen is synthesised as procollagen, with extra pro-
undergoing elective repair of asymptomatic infrarenalpeptide domains at both ends (Fig. 1). Part of type III
AAA, and two samples had been taken during emer-collagen is known to be present in tissues as type III
gency operations after rupture. All the aneurysms
were degenerative and fusiform, and their maximum
∗ Please address all correspondence to: Professor Juha Risteli, De- diameters (mean 6.1 cm, range 3.0 to 13.0 cm) had beenpartment of Clinical Chemistry, P.O.B. 5000, FIN-90014, University
of Oulu, Finland. measured preoperatively by ultrasonography. All the
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0.04% Tween 20 was added up to 1 ml/100 mg of wet
tissue weight. The samples were homogenised and
centrifuged, and the supernatants (soluble fractions)
were collected for analyses as described earlier.14 The
pellets (insoluble fractions) were treated with sodium
borohydride (50 mg NaBH4/g tissue weight) to sta-
bilise the possibly reducible collagen cross-links. Fats
were removed by washing briefly with acetone/meth-
anol (1:2, v/v) and finally with ethanol, followed by
centrifugation and collection of the pellet. The pellets
were freeze-dried, weighed and suspended in 0.2 mol/
l NH4HCO3 (1 ml/10 mg dry weight), denatured at
+70 °C for 1 h and treated with 1 mg of trypsin per
100 mg of sample. The digestions were performed for
4 h at +37 °C, after which the samples were again
denatured, homogenised and retreated overnight with
a similar amount of fresh trypsin. The residual trypsin
activity was destroyed at +70 °C, and the samples
were centrifuged at 10 000×g for 30 min. The super-
natants were collected for immunochemical and gel
filtration analysis.
Immunoassays for type III collagen metabolites
Fig. 1. (A) Schematic representation of the structure of procollagens
(upper) and cross-linked collagens (lower). N-pro, aminoterminal
propeptide; C-pro, carboxyterminal propeptide; N-telo, amino- The concentration of the aminoterminal propeptide of
terminal telopeptide, and C-telo, carboxyterminal telopeptide of the type III procollagen, PIIINP15 (Orion Diagnostica), was
collagen molecule. The open arrows indicate the N- and C-proteinase
measured under equilibrium conditions in 1:10 di-cleavage sites for removal of the propeptides. In the lower figure
(left), note the localization of a trivalent hydroxylysyl pyridinoline lutions of the tissue extracts and in dilutions varying
cross-link between neighboring collagen molecules, representing from 1:1 to 1:100 of the tissue digests, the former for
the cross-linked aminoterminal telopeptide region (e.g. IIINTP).
the AODs and the latter for the AAAs. The intra- andThere may also be cross-links at C-telo. Sometimes the amino-
terminal propeptide of type III collagen (PIIINP) is not removed, interassay coefficients of variation were 4 and 5%.
resulting in type III pN-collagen. (B) Schematic illustration of the The concentrations of PIIINP observed in the trypsin
aminoterminal propeptide of type III procollagen (PIIINP). The bars
digests were multiplied by two to obtain the realindicate the location of disulfide bonds between cysteine residues.
The arrows indicate the theoretically possible trypsin cleavage sites. values, because this enzyme digestion decreases the
The arrow furthest to the right is most likely used when the smaller immunoreactivity of PIIINP by 50%.14 The con-
PIIINP form is generated.
centration of IIINTP, which represents the amino-
terminal telopeptide of type III collagen14 (in-housepatients had negative family histories concerning an-
method), was analysed in undiluted tissue extractseurysms. Control samples were obtained from the
and in tissue digests diluted from 1:100 to 1:1000. Theabdominal aortas of ten cadavers with manifest aorto-
intra- and interassay coefficients of variation were 6iliac occlusive disease (AOD) (8 men and 2 women,
and 10%.mean age 71 years, range 64 to 79 years) at autopsies
performed within 24 h of death. All the specimens
were stored frozen at −20 °C until processed. The
collection of tissue samples was approved by the local Trypsin digestion of PIIINP
Ethical Committee and conformed to the principles of
the Declaration of Helsinki. The intact aminoterminal propeptide of type III pro-
collagen, PIIINP, was purified from human ascitic fluid
as described earlier15 and digested with trypsin at
+37 °C after heat denaturation at +70 °C.14 The di-Preparation of samples
gestion products were purified by Sephacryl S-100 gel
filtration and chromatographies on a reverse-phase C8,The tissue specimens of 0.27–5.95 g were cut into small
pieces, and phosphate-buffered saline containing a DEAE, and finally a reverse-phase C18 column.
Eur J Vasc Endovasc Surg Vol 23, May 2002
Type III pN-collagen in AAA 415
A smaller trypsin-generated fragment of PIIINP was free propeptide, in a position corresponding to type
III pN-collagen molecules (Fig. 3A). In the AODs mostsimilarly purified from the tissue type III pN-collagen
of human uterine leiomyoma. The purification was of the antigenicity was due to the free propeptide,
indicating that type III procollagen had been com-followed with the PIIINP assay.15
The purities and apparent sizes of the different pletely processed (Fig. 3B).
The PIIINP antigens in the insoluble fraction wereforms of PIIINP were determined in 18% SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE) under obtained into solution by trypsin digestion and
similarly analysed by gel filtration on Sephacrylnonreducing and reducing conditions. The true mo-
lecular weights were determined by MALDI-TOF mass S-100 (Fig. 2). The proteolytic digestion releases the
propeptide domain from the pN-collagen molecule.spectrometry (BiflexTM, Bruker-Franzen Analytic).
Detectable amounts of PIIINP were seen in the AAAs
(Figs. 2A–C), whereas practically no such antigen was
seen in the AOD samples (Figs 2D–F), again suggesting
Statistical analyses differences in the processing of the biosynthetic pre-
cursors of type III collagen between the two situations.
Statistical analyses were carried out with the SPSS Most of the PIIINP antigen solubilised by trypsin from
statistical analysis tool. The significances of the dif- the insoluble aortic matrix eluted in one major peak
ferences between two groups were calculated with the (fractions 43–49), although some antigen, representing
non-parametric Mann–Whitney U-test. The data are a clearly smaller molecule, was found in the fractions
expressed as means with 95% confidence intervals (CI). 61–64 (Fig. 2).
Spearman’s rank correlation was used for correlation
analysis.
Characterization of trypsin digestion peptides of PIIINP
To elucidate the nature of the PIIINP antigens releasedResults
from aortic tissue by trypsin digestion, we compared
them with the tryptic digestion products of solubleSizes of the cross-linked type III collagen telopeptide
intact PIIINP from ascitic fluid (larger antigen) and ofantigens in digested aorta tissue
insoluble type III pN-collagen from leiomyoma (small
antigen). In SDS-PAGE, the latter was found not toThe cross-linked type III collagen telopeptide antigens
contain disulphide bonds (similar mobility with andin the trypsin digests of aortic tissue were analysed
without reduction; Fig. 4). The reduced individualby gel filtration (Fig. 2). In both the AAA and the
chains of the standard propeptide were clearly largerAOD tissue samples, the majority of the IIINTP antigen
than this.eluted in one peak corresponding to the trypsin-gen-
As expected, the intact standard PIIINP that haderated standard antigen that has been isolated pre-
been isolated without proteolytic treatment containedviously and is known to be this aminoterminal part
only disulphide-bound polypeptide chains in trimericof the type III collagen molecule in a trivalently cross-
structures. Trypsin treatment of this protein producedlinked form.14 In addition, minor amounts of smaller
a larger PIIINP-related antigen that resolved into threemolecular species representing divalently cross-linked
different components in SDS-PAGE without reduction.and non-cross-linked type III collagen telopeptides
Upon reduction, these gave rise only to two poly-were seen, especially in the AOD samples (Fig. 2).
peptide chains, one corresponding to the monomer of
standard PIIINP and the other to the smaller trypsin-
generated form (Fig. 4).
The real molecular sizes were assessed with MALDI-Aminoterminal propeptide antigens of type III procollagen
in aorta tissue TOF analysis. The intact PIIINP gave a molecular mass
of 43 258, as expected on the basis of known sequence
78% (CI 69–86%) of the PIIINP antigen was easily data. The size of the small antigen produced from
pN-collagen was 10 604, indicating that the trypsinextractable from the tissue in the atherosclerotic aortas,
as expected, but in the aneurysms most of it was cleavage most probably has occurred after the amino
acid residue Arg-95 and removed the most car-surprisingly associated with the insoluble matrix and
only 6% (CI 4–8%) found in the soluble fraction. In boxyterminal part of the propeptide that contains the
disulphide bonds (Fig. 1). The molecular weight dis-Sephacryl S-300 gel filtration a major part of the anti-
genicity of the AAA samples eluted far ahead of the tribution of the larger trypsin-treated PIIINP was
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Fig. 2. Gel filtration (Sephacryl S-100 column) profiles of the antigenicities of the cross-linked aminoterminal telopeptide of type III
collagen (IIINTP; open symbols) and the aminoterminal propeptide of type III procollagen (PIIINP; closed symbols) in trypsin-digested
insoluble matrices isolated from (A–C) AAAs; and (D–F) AODs. Note the marked difference between the AAAs and AODs in the amounts
of trypsin-digested PIIINP antigen, the major and minor elution positions of which are indicated by the arrows. The arrows indicate the
verified elution positions of the larger and smaller forms of trypsin-generated PIIINP.
heterogeneous, as expected from the SDS-PAGE ana- the PIIINP radioimmunoassay, the small antigen being
30 times less effective as inhibitor than the larger (Fig.lysis. Here the main form had a size of 11 054, sug-
gesting some difference either in the trypsin cleavage 5).
site(s) or in the post-translational modifications be-
tween this and the small antigen from pN-collagen.
Our conclusion is that trypsin had cut one or two of
the three component chains in soluble, intact PIIINP Increased amounts of biochemical precursor forms of type
III collagen(Fig. 1B) and that such cleavage products still partially
adhered to the rest of the propeptide.
In order to exclude a decreased rate of synthesis ofIn Sephacryl S-100 gel exclusion chromatography
the elution position of the larger trypsin-generated type III collagen as the reason for the difference in the
proportions of fibrillar collagens between AAA andPIIINP antigen corresponded to the major PIIINP peak
found for the trypsin-digested AAA samples (Fig. 2). AOD, we quantified the aminoterminal propeptide of
type III procollagen in both the soluble and the in-The minor component of fractions 61–64 corresponded
to the elution position of the small antigen. soluble fractions of tissues (Fig. 6). Although the sol-
uble fraction only contains about one per cent ofThere was also a major difference between the two
trypsin-generated antigen forms in their behaviour in total collagen, the molecules that are in transit from
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Fig. 3. Gel filtration (Sephacryl S-300) profiles of the antigenicity of
PIIINP in soluble extracts of (A) AAA; and (B) AOD. The first arrow
indicates the exclusion volume of the column, where type III pN-
procollagen also elutes, and the second arrow denotes the elution
position of standard PIIINP. The elution of total protein is monitored Fig. 4. Effect of trypsin digestion on the aminoterminal propeptide
by absorbance at 280 nm. of type III procollagen. Intact PIIINP and both trypsin-generated
forms were analyzed on 18% SDS-PAGE. (A) 1. Intact PIIINP, 2. The
larger trypsin-digested form of intact PIIINP, 3. The smaller formbiosynthesis to collagen fibres as well as the free
of PIIINP derived from trypsin-digested tissue type III pN-collagen.
propeptides released during synthesis are normally (B) The same samples under reducing conditions: 1. Intact PIIINP
has only identical monomeric chains after reduction. 2. The truncatedrecovered in this fraction.
form of PIIINP has two monomeric propeptide chains, both uncle-In the soluble extracts, the amount of type III pN-
aved (compare lane 1) and cleaved (compare lane 3). 3. When the
collagen (as a percentage of the sum of type III pN- digestion with trypsin is complete, a smaller, non-reducible chain
appears. Globular standard proteins with the indicated molecularcollagen and type III collagen, which were calculated
masses were run on both sides of the samples, although theyfrom the molar amounts of PIIINP and IIINTP, re-
give too high apparent molecular weights for proteins containing
spectively) accounted for 69% and 41% of the total type collagenous sequences (such as PIIINP).
III collagen in AAAs and AOD samples, respectively
(p<0.001) (Table 1). As mentioned above, there were,
unexpectedly, significant amounts of the propeptide
III pN-collagen staining in the media of aneurysms,antigen also in the insoluble matrix in the AAAs,
which suggested a role of type III collagen in aneurysmwhere the proportion of type III pN-collagen was
formation.17 The present study gives direct biochemical0.74%, whereas the corresponding proportion in the
evidence that the proportion of incompletely processedAOD specimens was 0.06% (Table 1, Figs 2 and 6).
type III pN-collagen is, indeed, high in AAAs (Table
1). However, the overall rate of type III collagen syn-
thesis did not seem to be increased, since there was
no increase in the amount of free propeptide derivedDiscussion
from the complete processing of type III procollagen
in the soluble extract (Fig. 3). These findings suggestAneurysm formation is a complex remodelling process
that involves both synthesis and degradation of extra- a possibly delayed maturation of type III collagen.
The analysis of the soluble extracts gives informationcellular matrix proteins.16 In recent immuno-
histochemical studies we have found abundant type on the rate of turnover of extracellular matrix proteins,
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Fig. 5. Antigenicities of the two trypsin-generated forms of PIIINP
and an intact PIIINP standard. Serial dilutions (starting from 500
(g/L) of the trypsin-generated larger (Φ–Φ) and smaller (Β–Β)
PIIINP antigens are compared as inhibitors in the radioimmuno
inhibition assay for intact PIIINP (Χ–Χ). The concentrations of the
larger and smaller trypsin-digested peptides giving 50% inhibition
are 12.5 g/l and 375 g/l, respectively. There is also a small dif-
ference between the slopes of the linear parts of the inhibition Fig. 6. Distributions of the absolute amounts of PIIINP in the (A)curves33 with intact PIIINP having a slope of −1.070, the larger insoluble and (B) soluble fractions of AAA (closed circles) andtrypsin-generated PIIINP antigen −0.951 and the smaller trypsin- AOD (open circles) samples. The dashed lines indicate the meangenerated PIIINP antigen −0.800. concentrations, which are in the insoluble fractions (A) 14.94 g/g
(CI 2.55–27.33 g/g) for AAA and 0.27 g/g (CI 0.13–0.41 g/g) for
AOD (p<0.0001), and in the soluble fractions (B) 0.68 g/g (CI
since their biosynthetic precursors are normally re- 0.51–0.84 g/g) for AAA and 1.15 g/g (CI 0.68–1.63 g/g) for AOD
(p<0.013). Note the logarithmic scale in Figure A.covered in this fraction. Although the extract only
represents a quantitatively small part of the total
amount of collagens in tissue, it is relevant for assessing PIIINP that was released from insoluble aortic matrix
by trypsin was still in the larger form, instead of thisthe amounts of procollagens, partially processed pro-
collagens and non-cross-linked collagens (Fig. 1). We small end product. Thus, we could use the same
correction factor 2 as in our previous study on ath-compared AAAs with AODs, since these are two
anatomically distinct disease processes that are both erosclerotic plaques14 for calculating the real con-
centration of type III pN-collagen in the tissue.associated with atherosclerosis.16 This was also ap-
propriate because of the controversy concerning the Collagen continues to be synthesised throughout
the human life span, and the collagen contents ofrole of atherosclerosis in the pathogenesis of AAAs,
as the aneurysms in this study were also associated tissues reflect the net effects of synthesis and de-
gradation. Recently we provided evidence for in-with atherosclerosis.
In this study, we further validated our method for creased type III collagen turnover in AAA by
demonstrating increased concentrations of PIIINP inestimating the amount of tissue type III pN-collagen,
which involves trypsin digestion. The end product of AAA patients’ blood.18 This suggests that the re-
modelling of type III collagen is enhanced in AAA,such digestion of PIIINP was found to be the most
aminoterminal part of the propeptide, and the size of even within the stable aneurysm wall. Our follow-up
study, in which the growth of the aneurysm led to anthis digestion product was confirmed by MALDI-TOF
analysis. The intermolecular disulphide bridges at the accelerated turnover of type III collagen, also pointed
out that aortic tissue has a capacity to react to demandscarboxyterminal end of the intact PIIINP had thus been
digested away (Fig. 1B), and the immunoreactivity was for repair.19 This assumption is also supported by the
reported positive correlation between the increasingalso significantly reduced (Fig. 5). However, our gel
filtration analyses (Fig. 2) confirmed that most of the aneurysm size and circumferential collagen content.20
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Table 1. Type III pN-collagen as percentage (mean and 95% confidence interval, CI) of the total amount of
type III collagen in AOD and AAA and the increases in AAA compared with AOD.
Sample AOD AAA AAA compared with AOD
(multiples)
Soluble extract 41% 69% ×1.7
CI 30–51 CI 61–77 p<0.001
Insoluble matrix 0.061% 0.739% ×12.1
CI 0.042–0.081 CI 0.496–0.982 p<0.0001
Our present results demonstrated that there is much to frameshift mutations, in turn, leads to decreased
production of type III collagen.27 Furthermore, themore type III pN-collagen in AAAs than in the vessel
walls of patients with AODs (Fig. 6). As pN-collagen phenotype of mice lacking type III collagen resembles
the clinical manifestations of the EDS IV.28 There iscan normally only occur on the surface of collagen
fibres, its accumulation in tissue suggests impaired evidence that the proportion of type III collagen is
lower in some cases of AAAs than in controls.29,30 Information of the fibrillar structure and secondary in-
terference with collagen cross-linking. As proper cross- addition, it has been reported that type III collagen
production is decreased in cultured skin fibroblastslinking, however, is necessary to maintain normal
tensile strength of the tissue, this could result in weaker from familial AAA patients.31 Furthermore, unusual
fragments of type III collagen have been found aftermechanical properties. Thus, incomplete processing of
type III collagen, even to a seemingly minor degree, pepsin digestion of atherosclerotic AAAs.32 In the pres-
ent study, the proportion of type III pN-collagen inis likely to affect aneurysm stability.
Even though there are clear differences between AAA tissue was higher than in corresponding AOD
without aneurysmal changes. In principle we cannotAAA and AOD samples in their contents of type III
pN-collagen (Table 1), the absolute amount of type III exclude a genetic variation in the type III procollagen
gene as the reason for this, although our patients hadpN-collagen is still quite small in both. This leads to
a conclusion that collagen turnover in AAAs is a no family history of the disease. However, the synthesis
of type III procollagen did not seem to be significantlyrelatively balanced process. In a more advanced state,
however, the increased rate of type III collagen meta- decreased when analysed quantitatively (Fig. 6).
bolism may exceed the rate of proper processing of
collagens, impair tensile strength and thus predispose
the vessel wall to rupture. In addition, the incompletely
Acknowledgementsprocessed type III pN-collagen may be more sus-
ceptible to proteolytic attack than completely pro- The authors gratefully acknowledge the expert technical assistance
cessed collagen. This is supported by the increased of Ms. Pa¨ivi Annala, Ms. Tiina Holappa and Dr. Aimo Heina¨ma¨ki,
Ph.D.solubility of collagens in AAA tissue reported.21 In-
creased activities of specific matrix metalloproteinases
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tissue9–11 and in blood22 in the patients with AAA.
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